CID 11335389

Normacusine b

Structural Information

Molecular Formula
C19H22N2O
SMILES
C/C=C\1/CN2[C@H]3C[C@@H]1[C@H]([C@@H]2CC4=C3NC5=CC=CC=C45)CO
InChI
InChI=1S/C19H22N2O/c1-2-11-9-21-17-8-14-12-5-3-4-6-16(12)20-19(14)18(21)7-13(11)15(17)10-22/h2-6,13,15,17-18,20,22H,7-10H2,1H3/b11-2-/t13-,15+,17-,18-/m0/s1
InChIKey
VXTDUGOBAOLMED-VICVVEARSA-N
Compound name
[(1S,12S,13R,14R,15E)-15-ethylidene-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraen-13-yl]methanol
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

294.17322 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 295.180496 164.3
[M+Na]+ 317.162438 169.8
[M-H]- 293.165944 160.1
[M+NH4]+ 312.207043 184.0
[M+K]+ 333.136378 162.0
[M+H-H2O]+ 277.170480 156.1
[M+HCOO]- 339.171421 168.9
[M+CH3COO]- 353.187071 171.9
[M+Na-2H]- 315.147886 170.5
[M]+ 294.17267142 163.4
[M]- 294.17376858 163.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.